ClinicalTrials.gov
public full text
Public Domain
Paliperidone ER(Invega®) on Depressive Symptoms of Schizophrenia Patients
The purpose of this study is changing (improving), after initiating various doses of Paliperidone ER on schizophrenia patients.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Comparison of Berberine and Metformin for the Treatment for MS in Schizophrenia Patients#429722
- Compatible Effect of Remimazolam Besylate Combined With Afentanil for ATI#979583
- Functional and Neurochemical Correlates of Treatment Response in Major Depressive Disorder#1085595
- 3-Week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07008)#1009369
- Animal Models for Drug Discovery in Schizophrenia: A Critical View from a Clinical Perspective.#662621
Record · ID 1075551
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive